Magnolia Oil & Gas Acquires WildFire Energy in $4.06 Billion Deal to Expand South Texas Footprint
The deal adds over 810,000 net acres, boosts production by 53,000 boe/d, and includes key infrastructure assets.
NOTRELOAD AI
RBC Bullish on Nuvation Bio as Safusidenib Delivers Durable Responses in Glioma with New Phase 3 and Phase 2 Studies
Nuvation Bio reports strong long-term Phase 2 data for safusidenib (52% ORR, 79% PFS) and announces new Phase 3 and Phase 2 studies in IDH1-mutant glioma.
Archer and Anduril Unveil Thunder: Autonomous Hybrid VTOL for Commercial and Defense Missions
The autonomous platform offers extended range and is set for first flight in 2027.
Armata Clears Key FDA Milestone, Prepares AP-SA02 Phase 3 Trial for 2026
Armata Pharmaceuticals reaches key regulatory milestone with FDA submission for AP-SA02 Phase 3 trial. Lead bacteriophage candidate targets serious S. aureus infections with new DoD funding.
Microsoft Deploys AMD Helios Racks in Azure, Boosting AMD’s Push Against Nvidia Dominance
Lower cost per token and strong TCO position AMD to gain AI market share from Nvidia.
Rhode Island’s Most Wanted Fugitive Lived as Biotech CMO — Arrested After 21 Years on the Run
Ronald Fischer, convicted of sexual assault, evaded justice for over two decades while living under the alias Richard Graydon as CMO of Immix Biopharma.